Use of the Dash Diet and Coronary Artery Disease

Authors

Matthew W. McMaster, From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Dikshya Sharma, Department of Cardiology, Westchester Medical Center, Valhalla, NY.
Paritosh Kafle, Department of Medicine, Maimonides Medical Center, Brooklyn, NY.
William H. Frishman, From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.
Wilbert S. Aronow, From the Department of Medicine, Westchester Medical Center and New York Medical College, Valhalla, NY.

Author Type(s)

Student, Faculty

Journal Title

Cardiology in Review

First Page

153

Last Page

156

Document Type

Article

Publication Date

3-1-2024

Department

Medicine

Abstract

Initial dietary approach to stop hypertension (DASH) diet feeding trials showed blood pressure (BP)-lowering effects that corresponded to higher degrees of concordance with the diet. These results popularized the idea that adherence to a DASH diet could reduce coronary artery disease (CAD) risk for patients. Recent evidence shows that the impact of DASH on CAD incidence and risk is less clear. While many studies show that the DASH diet impacts CAD risk factors, others suggest that these effects do not remain when important confounders are controlled. Also, the evidence from meta-analyses that the DASH diet impacts incident CAD is still inconclusive. Reassessment of the DASH diet, and the search for an ideal diet to prevent CAD will require a better understanding of the mechanisms through which the DASH diet works. Proposed mechanisms for its benefit include preventing inflammation and atherosclerosis progression as well as providing a heathy balance of dietary sodium and potassium intake.

Recommended Citation

McMaster, M. W., Sharma, D., Kafle, P., Frishman, W. H., & Aronow, W. S. (2024). Use of the Dash Diet and Coronary Artery Disease. Cardiology in Review, 32 (2), 153-156. https://doi.org/10.1097/CRD.0000000000000482